Effects of onabotulinum toxin type A injections in patients with Meige's syndrome.
Alexia DuarteLéo CoutinhoFrancisco Manoel Branco GerminianiHélio Augusto Guizoni TeivePublished in: Arquivos de neuro-psiquiatria (2024)
Our results support that OBTA seems to be an effective and safe therapeutic option for treating Meige's syndrome. The effect of OBTA was more pronounced in the treatment of blepharospasm than in oromandibular dystonia.